Insider · CIK 0001452629
Kirk A Davis
Files at HHS (HARTE HANKS INC). First filing Nov 16, 2023, latest Aug 12, 2024.
In brief
Kirk A Davis files SEC Form 4 as CEO at HHS (HARTE HANKS INC). Since Nov 16, 2023, Kirk A Davis has reported 3 open-market buys worth $141k and 0 open-market sells worth $0, the latest filed on Aug 12, 2024.
A track record needs three past buys with six months of prices behind them; Kirk A Davis has 1, so none is measured yet.
The newest scored trade: bought $50k of HHS on Aug 12, 2024, filed Aug 12, 2024, scored 57 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HHS: HARTE HANKS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | HARTE HANKS INC | $50k 7,143 shares | +32% | +27% from low-22% from high | |
| 46Moderate | HARTE HANKS INC | $50k 7,050 shares | +46% | +38% from low-11% from high | |
| 57Moderate | HARTE HANKS INC | $41k 5,739 shares | +60% | +38% from low-49% from high |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +7,082 | $7.00 | $50k | 29,413 | Aug 12, 2024 |
| Aug 12, 2024 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +61 | $6.96 | $425 | 29,474 | Aug 12, 2024 |
| May 13, 2024 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +1 | $7.08 | $7 | 15,282 | May 13, 2024 |
| May 13, 2024 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +221 | $7.07 | $1,562 | 15,503 | May 13, 2024 |
| May 13, 2024 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +400 | $7.09 | $2,836 | 15,903 | May 13, 2024 |
| May 13, 2024 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +6,000 | $7.10 | $43k | 21,903 | May 13, 2024 |
| May 13, 2024 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +300 | $7.00 | $2,100 | 22,203 | May 13, 2024 |
| May 13, 2024 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +1 | $6.99 | $7 | 22,204 | May 13, 2024 |
| May 13, 2024 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +127 | $7.01 | $890 | 22,331 | May 13, 2024 |
| Nov 15, 2023 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +3,500 | $7.09 | $25k | 13,042 | Nov 16, 2023 |
| Nov 15, 2023 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +1,223 | $7.08 | $8,659 | 14,265 | Nov 16, 2023 |
| Nov 15, 2023 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +50 | $6.98 | $349 | 14,315 | Nov 16, 2023 |
| Nov 15, 2023 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +400 | $6.97 | $2,788 | 14,715 | Nov 16, 2023 |
| Nov 15, 2023 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +400 | $6.96 | $2,784 | 15,115 | Nov 16, 2023 |
| Nov 15, 2023 | HHS HARTE HANKS INC | POpen-market purchase Common Stock | +166 | $6.97 | $1,157 | 15,281 | Nov 16, 2023 |
Questions about Kirk A Davis
Answered from the filings on this page, as of the latest one.
Is Kirk A Davis buying or selling?
Not in the last 12 months. Kirk A Davis's latest open-market trade on SEC Form 4 was bought $50k of HHS on Aug 12, 2024.
How did Kirk A Davis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kirk A Davis has 1.
Where does Kirk A Davis file Form 4?
Kirk A Davis has filed Form 4 at HHS (HARTE HANKS INC) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.